Q fever historical perspective

Jump to navigation Jump to search

Q fever Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Q fever from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary prevention

Secondary prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Q fever historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Q fever historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Q fever historical perspective

CDC on Q fever historical perspective

Q fever historical perspective in the news

Blogs on Q fever historical perspective

Directions to Hospitals Treating Q fever

Risk calculators and risk factors for Q fever historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The disease was first described by Edward Holbrook Derrick in Australia while the pathogen was first described in 1937 by Frank Macfarlane Burnet.

Historical Perspective

Biological warfare

  • Q fever has been described as a possible biological weapon.[5]
  • The United States investigated Q fever as a potential biological warfare agent in the 1950s, with eventual standardization as agent OU. At Fort Detrick and Dugway Proving Ground, human trials were conducted on Whitecoat volunteers to determine the median infective dose (18 MICLD50/person i.h.) and course of infection.
  • As a standardized biological, it was manufactured in large quantities at Pine Bluff Arsenal, with 5,098 gallons in the arsenal in bulk at the time of demilitarization in 1970.
  • Q fever is a category "B" agent.[6] It can be contagious, and is very stable in aerosols in a wide range of temperatures. Q fever microorganisms may survive on surfaces up to 60 days.

References

  1. Derrick EH. Q" fever a new fever entity: clinical features. diagnosis, and laboratory investigation. Med J Aust. 1937;11:281-299.
  2. Joseph E. McDade (1990). "Historical Aspects of Q Fever". In Thomas J. Marrie. Q Fever, Volume I: The Disease. CRC Press. p. 8. ISBN 0-8493-5984-8.
  3. Burnet FM, Freeman M. Experimental studies on the virus of “Q” fever. Med J Aust 1937; 2: 299-305.
  4. Davis, G. E., and H. R. Cox. 1938. A filter-passing infectious agent isolated from ticks. I. Isolation from Dermacentor andersonii, reactions in animals, and filtration. Public Health Rep. 53:2259-2282.
  5. Madariaga MG, Rezai K, Trenholme GM, Weinstein RA (2003). "Q fever: a biological weapon in your backyard". Lancet Infect Dis. 3 (11): 709–21. doi:10.1016/S1473-3099(03)00804-1. PMID 14592601. Unknown parameter |month= ignored (help)
  6. Seshadri R, Paulsen IT, Eisen JA; et al. (2003). "Complete genome sequence of the Q-fever pathogen Coxiella burnetii". Proc. Natl. Acad. Sci. U.S.A. 100 (9): 5455–60. doi:10.1073/pnas.0931379100. PMC 154366. PMID 12704232. Unknown parameter |month= ignored (help)

Template:Help Menu Template:Sources